174 related articles for article (PubMed ID: 34528760)
1. Modeling glioblastoma heterogeneity as a dynamic network of cell states.
Larsson I; Dalmo E; Elgendy R; Niklasson M; Doroszko M; Segerman A; Jörnsten R; Westermark B; Nelander S
Mol Syst Biol; 2021 Sep; 17(9):e10105. PubMed ID: 34528760
[TBL] [Abstract][Full Text] [Related]
2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
3. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.
Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D
Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143
[TBL] [Abstract][Full Text] [Related]
4. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.
Krieger TG; Tirier SM; Park J; Jechow K; Eisemann T; Peterziel H; Angel P; Eils R; Conrad C
Neuro Oncol; 2020 Aug; 22(8):1138-1149. PubMed ID: 32297954
[TBL] [Abstract][Full Text] [Related]
5. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
6. Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data.
Lopes MB; Vinga S
BMC Bioinformatics; 2020 Feb; 21(1):59. PubMed ID: 32070274
[TBL] [Abstract][Full Text] [Related]
7. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Neftel C; Laffy J; Filbin MG; Hara T; Shore ME; Rahme GJ; Richman AR; Silverbush D; Shaw ML; Hebert CM; Dewitt J; Gritsch S; Perez EM; Gonzalez Castro LN; Lan X; Druck N; Rodman C; Dionne D; Kaplan A; Bertalan MS; Small J; Pelton K; Becker S; Bonal D; Nguyen QD; Servis RL; Fung JM; Mylvaganam R; Mayr L; Gojo J; Haberler C; Geyeregger R; Czech T; Slavc I; Nahed BV; Curry WT; Carter BS; Wakimoto H; Brastianos PK; Batchelor TT; Stemmer-Rachamimov A; Martinez-Lage M; Frosch MP; Stamenkovic I; Riggi N; Rheinbay E; Monje M; Rozenblatt-Rosen O; Cahill DP; Patel AP; Hunter T; Verma IM; Ligon KL; Louis DN; Regev A; Bernstein BE; Tirosh I; Suvà ML
Cell; 2019 Aug; 178(4):835-849.e21. PubMed ID: 31327527
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.
Qazi MA; Vora P; Venugopal C; Sidhu SS; Moffat J; Swanton C; Singh SK
Ann Oncol; 2017 Jul; 28(7):1448-1456. PubMed ID: 28407030
[TBL] [Abstract][Full Text] [Related]
9. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.
Meyer M; Reimand J; Lan X; Head R; Zhu X; Kushida M; Bayani J; Pressey JC; Lionel AC; Clarke ID; Cusimano M; Squire JA; Scherer SW; Bernstein M; Woodin MA; Bader GD; Dirks PB
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):851-6. PubMed ID: 25561528
[TBL] [Abstract][Full Text] [Related]
10. Relapse pathway of glioblastoma revealed by single-cell molecular analysis.
Chen X; Wen Q; Stucky A; Zeng Y; Gao S; Loudon WG; Ho HW; Kabeer MH; Li SC; Zhang X; Zhong JF
Carcinogenesis; 2018 Jul; 39(7):931-936. PubMed ID: 29718126
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.
Qazi MA; Salim SK; Brown KR; Mikolajewicz N; Savage N; Han H; Subapanditha MK; Bakhshinyan D; Nixon A; Vora P; Desmond K; Chokshi C; Singh M; Khoo A; Macklin A; Khan S; Tatari N; Winegarden N; Richards L; Pugh T; Bock N; Mansouri A; Venugopal C; Kislinger T; Goyal S; Moffat J; Singh SK
Cell Rep; 2022 Sep; 40(13):111420. PubMed ID: 36170831
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles.
Lin LT; Chiou SH; Lee TW; Liu RS; Hwang JJ; Chang CH; Ma HI; Lee YJ
Mol Imaging Biol; 2013 Jun; 15(3):262-72. PubMed ID: 22948536
[TBL] [Abstract][Full Text] [Related]
14. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
[TBL] [Abstract][Full Text] [Related]
15. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
16. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
[TBL] [Abstract][Full Text] [Related]
17. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
[TBL] [Abstract][Full Text] [Related]
18. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
Dirkse A; Golebiewska A; Buder T; Nazarov PV; Muller A; Poovathingal S; Brons NHC; Leite S; Sauvageot N; Sarkisjan D; Seyfrid M; Fritah S; Stieber D; Michelucci A; Hertel F; Herold-Mende C; Azuaje F; Skupin A; Bjerkvig R; Deutsch A; Voss-Böhme A; Niclou SP
Nat Commun; 2019 Apr; 10(1):1787. PubMed ID: 30992437
[TBL] [Abstract][Full Text] [Related]
20. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
